This is an observational, post-authorization, prospective follow-up, multi-centre, national study designed to describe the spectrum of health-related quality of life in patients with metastatic pancreatic cancer previously untreated with chemotherapy This study is designed to observe patients treated in routine clinical practice, without the exclusion limitations of a clinical trial. Patients will be enrolled in 7 Spanish sites. In all cases, the decision to treat patients will be performed prior to the decision to include the patient in the study.
SponsorsThis trial is sponsored by Celgene.
Interested in Clinical Trial?
Providers Associated With This Trial
- Thomas W. Butler, M.D.Medical OncologistSenior Staff Medical Oncologist, Medical Oncology Service; Associate Professor of Interdisciplinary Oncology
- Moh'd Khushman, M.D.Medical OncologistAssistant Professor of Interdisciplinary Clinical Oncology
- Sachin Pai, MBBS, M.D.Medical OncologistProgram Leader of Developmental Therapeutics; Assistant Professor of Interdisciplinary Clinical Oncology
- David R. Clarkson, M.D.Medical OncologistSenior Staff Physician, Medical Oncology Service; Professor of Interdisciplinary Clinical Oncology